1. Bartolini, A., Ghelardini, C., Donaldson, S., Galeotti, N., Nicolodi, M., and Sicuteri, F., 1996, The antimigraine drug ergotamine is endowed with antinociceptive activity. Pharmacol. Res.
35:58.
2. Fowler, P.A., Lacey, L.F., Thomas, M., Keene, O.N., Tanner, R.J.N., and Baber, N.S., 1991, The clinical pharmacology, pharmacokinetics and metabolism of sumatriptan. Eur. Neurol.
31:291–294.
3. Ghelardini, C., Galeotti, N., Figini, M., Imperato, A., Nicolodi, M., Sicuteri, F., Gessa, G.L., and Bartolini, A., 1996, The central cholinergic system has a role in the antinociception induced in rodents and guinea pigs by the antimigraine drug sumatriptan. J. Pharmacol. Exp. Ther.
279(2):301–306.
4. Goadsby, P. and Gundlach, A., 1991, Localization of 3H-dihydroergotamine-binding sites in the cat central nervous system: relevance to migraine. Ann. Neurol.
29:91–94.
5. May, A., Gijsman, H.G., Wallnofer, A., Jones, R., Diener, H.C., and Ferrari, M.D., 1996, Endothelin antagonist bosentan blocks neurogenic inflammation, but is not effective in aborting migraine attacks. Pain
67:375–378.